The news that BlackRock applied for an XRP Spot ETF turned out to be fake.
As Bitcoinsistemi.com, we stated that the news may not be true and that anyone can add an application to the Delaware website.
Bloomberg analyst said the following after the news that BlackRock applied for an XRP Spot ETF turned out to be false:
“Guys this is FAKE. XRP is currently trading where it was before rising 15%. There are a lot of people asking if the Ethereum trust application is real after seeing that the XRP trust is fake. This application was real. The Ishares Ethereum trust application is real and was approved via filing 19b-4 on Thursday. Only the XRP trust application was fake.”
First version of the news:
According to breaking information, Summers, who previously reported that BlackRock had registered a registration in Delaware for the Ethereum Spot ETF, reported that the company this time registered the Ishares XRP Trust product for the XRP Spot ETF.
This can't be real. Ishares XRP Trust registered in Delaware? pic.twitter.com/pA3PX7i8Wu
— Summers (@SummersThings) November 13, 2023
After the news, the XRP price saw a sudden increase to $0.72.
It is not known whether BlackRock has actually applied for an XRP Spot ETF yet, as anyone can add an application to Delaware's registration website.
Bloomberg analysts Eric Balchunas and James Seyffart made a statement on the subject.
Eric Balchunas: “BlackRock is at it again, applying to register the iShares XRP Trust (forerunner of ETF application). “When I saw others sharing it I thought it wasn't real, but now I checked and it is indeed on the Delaware corporation listing website.”
James Seyffart: “I didn't see this coming. It's definitely on the site. Application information similar to the Ethereum Trust application. This XRP trust, if this is indeed coming from BlackRock, could be a sign that BlackRock is actually going after the SEC. Is Larry just focusing here? “I'm trying to confirm if this belongs to BlackRock or if it's an elaborate scam/pump and dump.”
*This is not investment advice.